J. Safra Sarasin Holding AG Purchases New Shares in Axon Enterprise, Inc $AXON

J. Safra Sarasin Holding AG bought a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,898 shares of the biotechnology company’s stock, valued at approximately $2,399,000.

Other hedge funds have also added to or reduced their stakes in the company. TCTC Holdings LLC boosted its holdings in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its holdings in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise in the first quarter worth $32,000. Banque Transatlantique SA bought a new stake in Axon Enterprise in the first quarter worth $31,000. Finally, Flaharty Asset Management LLC bought a new stake in Axon Enterprise in the first quarter worth $33,000. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on AXON. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a report on Saturday, September 27th. JMP Securities reaffirmed a “market outperform” rating and set a $825.00 price target on shares of Axon Enterprise in a report on Monday, September 29th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Bank of America upped their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Finally, UBS Group reaffirmed a “neutral” rating and set a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $841.64.

Insider Activity

In other news, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares in the company, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,932 shares of company stock worth $37,978,216. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Down 0.7%

Axon Enterprise stock opened at $715.51 on Friday. Axon Enterprise, Inc has a 52-week low of $413.68 and a 52-week high of $885.91. The company has a market cap of $56.17 billion, a P/E ratio of 176.67, a P/E/G ratio of 27.98 and a beta of 1.41. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The business has a 50-day simple moving average of $757.79 and a two-hundred day simple moving average of $707.36.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm’s revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.